Early Management Strategies of Acute Heart Failure for Patients With NSTEMI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 470 participants.

Also called NCT03189901

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 470 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03189901
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03189901. Randomized; no masking; primary purpose treatment. Start 2017-07-01 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Management Strategies of Acute Heart Failure for Patients With NSTEMI
Acronym
EMSAHF
Condition
Early Management
Condition
Acute Heart Failure
Condition
NSTEMI - Non-ST Segment Elevation MI
Intervention (Drug)
Regular management+Levosimendan
Lead sponsor
Qilu Hospital of Shandong University (class: other)

Record details

Record id
cardio:ct-nct03189901
Content hash
7689459863635e883b68907e81e94b32b9828740a40e485c4b88e6c5aac1248e